Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
FRONTEO and Axcelead DDP Forge Essential AI-Enabled Drug Discovery Support Partnership
Monday, November 06, 2023FRONTEO Co Ltd and Axcelead Drug Discovery Partners Co Ltd have recently entered into a foundational partnership agreement to enhance AIdriven support for drug discovery FRONTEO specializes in the Drug Discovery AI Factory business
Zydus and Lupin Enter into a Licensing Agreement to Jointly Promote Saroglitazar Mg, an Essential Therapy for Chronic Liver Diseases in India
Saturday, November 04, 2023Zydus Lifesciences Limited and Lupin Limited have recently unveiled a collaborative licensing and supply agreement This partnership aims to comarket Saroglitazar Mg in India a medication designed for the treatment of NonAlcoholic Fatty Liver Disease
Chipscreen's New CS32582 Capsules Granted Clinical Approval for Psoriasis Treatment
Friday, November 03, 2023Shenzhen Chipscreen Biosciences Co Ltd with stock code SH has received approval from the National Medical Products Administration for clinical trials of CS capsules to treat psoriasis
Felzartamab Granted Breakthrough Therapy Designation for Primary Membranous Nephropathy (PMN) by the U.S. Food and Drug Administration (FDA)
Friday, November 03, 2023IMab a global biotechnology company listed on Nasdaq and HIBio a clinicalstage biotechnology company specializing in targeted therapies for patients with severe immunemediated diseases
CStone and 3SBio Establish Exclusive Licensing Agreement and Strategic Partnership for Nofazinlimab (Anti-PD-1 Antibody) in Mainland China
Thursday, November 02, 2023CStone Pharmaceuticals a leading biopharmaceutical company specializing in innovative immunooncology therapies and precision medicines has announced a strategic partnership and exclusive licensing agreement
CStone's Sugemalimab Granted NMPA Approval for Relapsed or Refractory Extranodal NK/T-cell Lymphoma, Pioneering the Anti-PD-1/PD-L1 mAb Approval in this Indication
Wednesday, November 01, 2023CStone Pharmaceuticals is a biopharmaceutical company listed on the Hong Kong Stock Exchange under the symbol They focus on the research development and commercialization of innovative immunooncology therapies
INtRON Enters into an Evaluation License and Option Agreement for SAL200
Wednesday, November 01, 2023INtRON Biotechnology operating under the name iNtRON and found at wwwintodeworldcom announced today that they have entered into an EVALUATION LICENSE AND OPTION AGREEMENT with Basilea Pharmaceutica Ltd of Allschwil
NurExone Biologic Secures FDA Orphan-Drug Designation to Expedite Development of ExoPTEN Therapy for Treating Acute Spinal Cord Injuries
Tuesday, October 31, 2023NurExone Biologic Inc a leading biotechnology company is delighted to announce that the US Food and Drug Administration has granted OrphanDrug Designation for its innovative therapy
Rational Vaccines and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Establish Collaboration for the Development of Herpes Vaccines in China
Tuesday, October 31, 2023Rational Vaccines and Shenzhen Mellow Hope Pharm Industrial Co Ltd recently announced a partnership to jointly develop manufacture and market live vaccines targeting herpes simplex viruses
Hengrui Pharmaceuticals and Merck KGaA, Darmstadt, Germany, Join Forces to Advance Innovative Cancer Therapies
Monday, October 30, 2023Jiangsu Hengrui Pharmaceuticals Co Ltd a global pharmaceutical company with a strong focus on scientific and technological innovation has announced a significant licensing agreement with Merck KGaA Darmstadt Germany
